Buradasınız

Morganella Morganii - Sürekli Ayaktan Periton Diyaliz Hastalarında Peritonitin Nadir Bir Nedeni

Morganella Morganii - A Rare Cause of Continuous Ambulatory Peritoneal Dialysis Peritonitis

Journal Name:

Publication Year:

DOI: 
10.5262/tndt.2014.1002.15
Abstract (2. Language): 
Nephrology professionals have selected continuous ambulatory peritoneal dialysis (CAPD) as the best initial therapy for patients who have chronic renal failure. Among complications, peritonitis continues to be one of the most important complications of CAPD. The typical spectrum of organisms causing peritonitis include Gram-positives (67%), Gram-negative rods (28%), fungi (2.5%), and anaerobics (2.5 %). Among Gram-negative bacterial species, Escherichia coli, Acinetobacter species, and Enterobacter are the most seen pathogens. In this report, we present a case of CAPD peritonitis due to Morganella morganii. To our knowledge, this presentation is the second report of CAPD peritonitis due to M. morganii.
Abstract (Original Language): 
Nefroloji uzmanları, kronik böbrek yetmezlikli hastalarında en iyi başlangıç tedavisi olarak sürekli ayaktan periton diyalizi (SAPD) tedavisi başlamayı seçerler. SAPD komplikasyonları arasında en önemlisi peritonitlerdir. Peritonite neden olan organizmalar arasında tipik spektrum; Gram-pozitifler (%67), Gram-negatif çomaklar (%28), mantarlar (%2,5) ve anaeroblardır (%2,5). Gram-negatif bakterilerden, Escherichia coli, Acinetobacter, ve Enterobacter en sık görülen patojenlerdir. Bu yazıda biz Morganella morganii nedenli SAPD peritonitini sunduk. Bilgilerimize göre bu bildiri Morganella morganii nedenli ikinci SAPD peritonit olgu sunumudur.
156
157

REFERENCES

References: 

1. Ledebo I, Ronco C: The best dialysis therapy? Results from an
international survey among nephrology professionals. NDT Plus
2008; 6: 403-408
2. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A,
Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk
DG; International Society for Peritoneal Dialysis: Peritoneal
dialysis-related infections recommendations: 2010 update. Perit
Dial Int 2010; 30(4): 393-423
3. Chaudhary K, Sangha H, Khanna R: Peritoneal dialysis first:
Rationale. Clin J Am Soc Nephrol 2011; 6(2): 447-456
4. Troidle L, Finkelstein F. Treatment and outcome of CPD-associated
peritonitis. Ann Clin Microbiol Antimicrob 2006; 5: 6
5. Yoon SH, Choi NW, Yun SR: Detecting bacterial growth in
continuous ambulatory peritoneal dialysis effluent using two culture
methods. Korean J Intern Med 2010; 25(1): 82-85
6. Donnenberg MS: Enterobacteriaceae. In Mandell GL, Bennett
JE, Dolin R (eds), Mandell, Benneett, and Dolin’s Principles and
Practice of Infectious Diseases (6th ed.). Philadelphia, PA: Churchill
Livingstone, 2005; 2567-2586
7. Kim JH, Cho CR, Um TH, Rhu JY, Kim ES, Jeong JW, Lee HR:
Morganella morganii sepsis with massive hemolysis. J Korean Med
Sci 2007; 22(6): 1082-1084
8. Kucukbayrak A, Ozdemir D, Yildirim M, Guclu E, Erdogmus B,
Akgul M, Gezen F: Multiple brain abscesses and mastoiditis due
to Morganella morganii after chronic otitis media. Case report and
literature review. Neurosurg Q 2007; 17: 294-296
9. Gautam V, Gupta V, Joshi RM, Sawhney G, Duhan S: Morganella
morganii-associated arthritis in a diabetic patient. J Clin Microbiol
2003; 41(7): 3451
10. Kim BN, Kim NJ, Kim MN, Kim YS, Woo JH, Ryu J: Bacteraemia
due to tribe Proteeae: A review of 132 cases during a decade (1991-
2000). Scand J Infect Dis 2003; 35(2): 98-103
11. Lee IK, Liu JW: Clinical characteristics and risk factors for mortality
in Morganella morganii bacteremia. J Microbiol Immunol Infect.
2006; 39(4): 328-334
12. Atalay H, Güney I, Solak Y, Almaz E: First case of CAPD-related
peritonitis caused by Morganella morganii. Perit Dial Int 2010;
30(1): 119-121

Thank you for copying data from http://www.arastirmax.com